The Therapeutic Role of Interleukin-1 Inhibition in Idiopathic Recurrent Pericarditis: Current Evidence and Future Challenges
Author:
Funder
National and Kapodistrian University of Athens
Publisher
Frontiers Media SA
Subject
General Medicine
Reference45 articles.
1. Recurrent pericarditis: new and emerging therapeutic options;Imazio;Nat Rev Cardiol,2016
2. Complicated pericarditis: understanding risk factors and pathophysiology to inform imaging and treatment;Cremer;J Am Coll Cardiol,2016
3. 2015 ESC guidelines for the diagnosis and management of pericardial diseases: the task force for the diagnosis and management of pericardial diseases of the European Society of Cardiology (ESC)endorsed by: The European Association for Cardio-Thoracic Surgery (EACTS);Adler;Eur Heart J,2015
4. Recurrent pericarditis: autoimmune or autoinflammatory?;Maestroni;Autoimmun Rev,2012
5. Anti-heart and anti-intercalated disk autoantibodies: evidence for autoimmunity in idiopathic recurrent acute pericarditis;Caforio;Heart,2010
Cited by 41 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Clinical Utility of Rilonacept for the Treatment of Recurrent Pericarditis: Design, Development, and Place in Therapy;Drug Design, Development and Therapy;2024-09
2. Novel Treatments in Refractory Recurrent Pericarditis;Pharmaceuticals;2024-08-15
3. Interleukin-1 Blockers: A Paradigm Shift in the Treatment of Recurrent Pericarditis;Life;2024-02-26
4. Interleukin-1 blockade for recurrent pericarditis: insights from the real-world experience;The Journal of Pediatrics;2023-07
5. Management of acute pericarditis;Current Opinion in Cardiology;2023-04-10
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3